Filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 10/31/2025

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 62 publications

Efficacy of Intravitreal Pegcetacoplan vs Avacincaptad Pegol in Patients With Geographic Atrophy.

Efficacy of Intravitreal Pegcetacoplan vs Avacincaptad Pegol in Patients With Geographic Atrophy.

Journal: Journal of vitreoretinal diseases
Published: October 20, 2025

Real-World Experience of Geographic Atrophy Treatment With Avacincaptad Pegol.

Real-World Experience of Geographic Atrophy Treatment With Avacincaptad Pegol.

Journal: Journal of vitreoretinal diseases
Published: September 08, 2025

Aptamers as therapeutic targets: prospects and progress in the treatment of cancers.

Aptamers as therapeutic targets: prospects and progress in the treatment of cancers.

Journal: Nucleosides, nucleotides & nucleic acids
Published: June 06, 2025

Silicone oil microdroplets from syringes with intravitreal anti-vascular endothelial growth factor and complement inhibitor injections.

Silicone oil microdroplets from syringes with intravitreal anti-vascular endothelial growth factor and complement inhibitor injections.

Journal: Retina (Philadelphia, Pa.)
Published: May 13, 2025

The 20th Anniversary of Pegaptanib (MacugenTM), the First Approved Aptamer Medicine: History, Recent Advances and Future Prospects of Aptamers in Therapy.

The 20th Anniversary of Pegaptanib (MacugenTM), the First Approved Aptamer Medicine: History, Recent Advances and Future Prospects of Aptamers in Therapy.

Journal: Pharmaceutics
Published: March 03, 2025

Ocular Adverse Events Associated with Pegcetacoplan and Avacincaptad Pegol for Geographic Atrophy: A Population-Based Pharmacovigilance Study.

Ocular Adverse Events Associated with Pegcetacoplan and Avacincaptad Pegol for Geographic Atrophy: A Population-Based Pharmacovigilance Study.

Journal: American journal of ophthalmology
Published: February 19, 2025

Real-World Outcomes with Complement Inhibitors for Geographic Atrophy: A Comparative Study of Pegacetacoplan versus Avacincaptad Pegol.

Real-World Outcomes with Complement Inhibitors for Geographic Atrophy: A Comparative Study of Pegacetacoplan versus Avacincaptad Pegol.

Journal: Clinical ophthalmology (Auckland, N.Z.)
Published: January 19, 2025

Valeda Light Delivery System for age-related macular degeneration.

Valeda Light Delivery System for age-related macular degeneration.

Journal: The Medical letter on drugs and therapeutics
Published: January 17, 2025

Drugs for age-related macular degeneration.

Drugs for age-related macular degeneration.

Journal: The Medical letter on drugs and therapeutics
Published: January 09, 2025

Innovative technologies for the treatment of dry age-related macular degeneration (AMD) - modern therapeutic perspectives and their future.

Innovative technologies for the treatment of dry age-related macular degeneration (AMD) - modern therapeutic perspectives and their future.

Journal: Romanian journal of ophthalmology
Published: January 07, 2025

Repurposing Dimethyl Fumarate Targeting Nrf2 to Slow Down the Growth of Areas of Geographic Atrophy.

Repurposing Dimethyl Fumarate Targeting Nrf2 to Slow Down the Growth of Areas of Geographic Atrophy.

Journal: International journal of molecular sciences
Published: January 06, 2025

The Safety of Recently Approved Therapeutics in Age-Related Macular Degeneration.

The Safety of Recently Approved Therapeutics in Age-Related Macular Degeneration.

Journal: International ophthalmology clinics
Published: December 23, 2024
Showing 1-12 of 62

Last Updated: 10/31/2025